Cost-effectiveness of allopurinol versus febuxostat in the treatment of gout patients: A systematic review

Background: In recent years, increased longevity, poor dietary habits, and the rising prevalence of metabolic syndrome and hypertension have increased the prevalence of gout. Gout significantly increases direct and indirect costs and reduces the quality of life. Allopurinol and febuxostat are the mo...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Med J Islam Repub Iran
Asıl Yazarlar: Rezapour, Aziz, Alidoost, Saeide, Asgharzadeh, Asra, Farhadi, Zeynab, Khodadadi, Najme, Mohammadi Bakhsh, Roghayeh, Sepehrian, Razieh, Salemi, Morteza, Taheri Mirghaed, Masood, Behzadifar, Masoud, Sohrabi, Rahim
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Iran University of Medical Sciences 2020
Konular:
Review Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7456432/
https://ncbi.nlm.nih.gov/pubmed/32884916
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.34171/mjiri.34.41
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller